Level 2 Professor, Chief Physician, Doctoral Supervisor, Academic Leader, Director of the Institute of Hematology
Affiliated HospitalSouthern Medical University Southern Hospital
→
Research areas : Molecular pathogenesis of leukemia, hematopoietic stem cell transplantation, tumor immunotherapy, and prevention and treatment of infections in immunocompromised hosts.
- Cutting-edge technologies: Haploidentical hematopoietic stem cell transplantation; MICM precision stratification therapy for leukemia; precision stratification therapy for acute leukemia (rewriting the NCCN/ELN guidelines); combined haploidentical and umbilical cord blood transplantation (Lancet RCT); MSC prevention of GVHD (earliest in China); sorafenib treatment for post-transplant AML (one of the top ten advances in Chinese hematology).
- Areas of expertise: Acute leukemia, aplastic anemia, refractory and relapsed hematological malignancies, refractory leukemia, lymphoma/myeloma, and hematological diseases requiring hematopoietic stem cell transplantation.
- Academic Highlights & Value: National Outstanding Physician (202), Vice Chairman of the Hematology Branch of the Chinese Medical Association, Head of the Infectious Diseases Group, Member of the Asia-Pacific Society of Hematology; presided over 3 National Key Research and Development Programs, 3 National Key Research and Development Programs, and 10 National Natural Science Foundation of China projects (including major/key projects); won 1 second prize of the National Science and Technology Progress Award and 3 first prizes at the provincial and ministerial levels; published more than 300 papers; twice selected as one of the Top Ten Research Advances in Hematology in China. Proposed a genetic stratification treatment strategy for leukemia to improve the long-term survival rate of patients, and the results have been incorporated into domestic guidelines.